Presentation Documents

Date	Title
02/21/24	Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease 191.3 KB
12/01/23	Improve Mean Arterial Pressure From Baseline to the End of Treatment With Terlipressin is Associated With Hepatorenal Renal Syndrome Reversal: A Pooled Analysis of Phase III Studies 2 MB
12/01/23	Albumin Dosing With Terlipressin for the Treatment of HRS-AKI: A Double-Edge Sword 2 MB
12/01/23	Decision-Analytic Model to Project the Benefit of Terlipressin Treatment Among Patients With Alcohol-Related Cirrhosis and HRS 2.4 MB
11/07/23	Terlipressin Treatment and Time to Clinical Response: Characterization of Hepatorenal Syndrome Reversal Using a Pooled Database of 3 Placebo-controlled Phase III Clinical Studies 2 MB
11/07/23	The Impact of MELD Score and ACLF Grade on Outcomes of Hepatorenal Syndrome Following Treatment With Terlipressin and Albumin in Patients With Alcohol-associated Hepatitis 2.2 MB
11/07/23	Albumin Dosing with Terlipressin for the Treatment of HRS-AKI: A Double-Edged Sword 2.6 MB
11/07/23	Patient Subset Analysis of the REVERSE Phase lll Study: The Impact of Terlipressin Treatment on Rates of Transplant, Dialysis, and Survival in Patients with Hepatorenal Syndrome 1.3 MB
11/07/23	Utility of Concurrent Administration of Albumin with Terlipressin for the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A Pooled Analysis of Two Randomized Controlled Trials 2.8 MB
11/07/23	Understanding the Relationship Between Mean Arterial Pressure and Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury Reversal: A Post Hoc Analysis of the CONFIRM, REVERSE, and OT-0401 Trials 1.4 MB
11/01/23	Improvements in Serum Creatinine was Associated with Favorable Clinical Outcomes in Patients with Hepatorenal Syndrome: A Post Hoc Analysis of the CONFIRM Study 492.5 KB
11/01/23	Terlipressin Therapy in Patients with HRS and Comorbidities: The North American Experience 492.3 KB
10/26/23	Differences in Patient Characteristics and Outcomes by Hospital Size for Patients with Chronic Liver Disease and Acute Kidney Injury or Hepatorenal Syndrome 1 MB
10/26/23	The Effect of Race on Treatment Response to Terlipressin in Patients with Hepatorenal Syndrome: A Pooled Analysis of 3 Phase III Clinical Studies 1.7 MB
10/26/23	The Effect of Terlipressin on Blood Pressure, Mean Arterial Pressure, and Heart Rate in Patients with Hepatorenal Syndrome: A Post Hoc Analysis of the CONFIRM Study 1.2 MB
10/19/23	Nephrotic Syndrome: Patient Characteristics, Treatment Patterns and Related Outcomes After Treatment with Acthar® Gel or Comparable Standard of Care in a Large Administrative Claims Database 1.6 MB
10/19/23	Cost-Effectiveness of Care Acthar®Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis 356.2 KB
04/10/23	Treatment-Related Cost Analysis for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function 2.5 MB
03/20/23	Corticosteroid use and adherence in patients treated with Acthar® Gel for advanced sarcoidosis 1.8 MB
03/07/23	TD Cowen Healthcare Conference Presentation 3-7-23 876.7 KB
05/17/22	ATS 2022 African Americans with Symptomatic Sarcoidosis Retrospective Analysis 881.5 KB